Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Elanco Animal Health Incorporated Common Stock (ELAN) vs Meta Platforms Inc (META) Price & Performance

Elanco Animal Health Incorporated Common StockTrade
Meta Platforms IncTrade

Price performance (Past 24H)

Key statistics

Elanco Animal Health Incorporated Common Stock vs Meta Platforms Inc — how do they compare? Elanco Animal Health Incorporated Common Stock trades at $22.62 (market cap $11.17B), while Meta Platforms Inc trades at $721.74 (market cap $1.84T). The key difference: Meta Platforms Inc is far larger — about 164.7× Elanco Animal Health Incorporated Common Stock's market cap, and Meta Platforms Inc pays a 0.29% dividend while Elanco Animal Health Incorporated Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Elanco Animal Health Incorporated Common Stock for 0 Days and Meta Platforms Inc for 127 Days on average.

ELANMETA
Market Cap
$11.17B$1.84T
Volume
4,196,24212,743,601
Sector
HealthMedia
52-Week High
$26.84$777.59
52-Week Low
$19.76$525.72
Typical Hold Time
0 Days127 Days
Enterprise Value
$14.56B$1.86T
Dividend Yield
—0.29%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Elanco Animal Health Incorporated Common Stock

No Aura AI signal available yet.

Meta Platforms Inc

Meta Platforms (META) trades at $720.89, down 2.43% on the day, with strong bullish technical signals from moving averages. The company demonstrates robust fundamentals with $201B revenue in 2025 and 29.8% net income margin, though Q2 2026 earnings missed expectations. Recent AI developments including the Muse Spark launch and a $21B partnership with CoreWeave highlight growth initiatives. Analyst consensus remains strongly bullish with 80% buy ratings and a $781 price target.

Meta presents a compelling investment case with strong profitability metrics and AI-driven growth potential, though faces regulatory risks from ongoing litigation and significant capital expenditure requirements. The stock's current valuation at 27x P/E appears reasonable given growth prospects, but investors should monitor execution on AI monetization and legal developments that could impact future earnings.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ELAN
100% Buy0% Sell
Avg holding period · 0 Days
META
73% Buy27% Sell
Avg holding period · 127 Days

Top news

Latest headlines on both assets

About Elanco Animal Health Incorporated Common Stock

Elanco develops medicines, vaccines, and other health products for pets and livestock. Its products address prevention and treatment of animal diseases.

Read more on ELAN →

About Meta Platforms Inc

Meta Platforms Inc., doing business as Meta and previously known as Facebook Inc. It's a company that acts as a parent platform for Facebook, Messenger, Instagram, Whatsapp, Oculus and other subsidiaries. Among these platforms, Facebook is the number one social media platform in terms of the number of active users.

Read more on META →